Hip the effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia

Orthopedics

Volumn 33, Issue 1, 2010, Pages 17-

  Kazemi, Seyyed Morteza ^a   Mosaffa, Faramarz ^b   Eajazi, Alireza ^c   Kaffashi, Mohammad ^b   Besheli, Laleh Daftari ^c   Bigdeli, Mohammad Reza ^a   Zanganeh, Ramin Farhang ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPIDURAL ANESTHESIA; EQUIPMENT DESIGN; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; HIP ARTHROPLASTY; METHODOLOGY; MIDDLE AGED; PREMEDICATION; TREATMENT OUTCOME;

ANESTHESIA, EPIDURAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 75649122555     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20091124-30     Document Type: Article

References (34)

1. Otsubo H, Yamaguchi K. Current risks in blood transfusion in Japan. Jpn J Infect Dis. 2008; 61(6):427-433.
2. Allain JP, Stramer SL, Carneiro-Proietti AB, et al. Transfusion- transmitted infectious diseases (published online ahead of print February 20, 2009). Biologicals. 2009; 37(2):71-77.
3. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention (published online ahead of print February 2, 2009). Blood. 2009; 113(15):3406-3417.
4. Tenholder M, Cushner FD. Intraoperative blood management in joint replacement surgery. Orthopedics. 2004; 27(6 suppl):s663-s668.
5. Harkness M, Palmer JB, Watson D, Walsh TS. A questionnaire-based survey of perioperative blood conservation practice for revision hip arthroplasty in Scotland. Transfus Med. 2008; 18(5):296-301.
6. Niemi TT, Pitkanen M, Syrjala M, Rosenberg PH. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand. 2000; 44(4):457-464.
7. Eroglu A, Uzunlar H, Erciyes N. Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J Clin Anesth. 2005; 17(6):420-425.
8. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006; 105(5):1034-1046.
9. Borghi B, Casati A, Iuorio S, et al. Effect of different anesthesia techniques on red blood cell endogenous recovery in hip arthroplasty. J Clin Anesth. 2005; 17(2):96-101.
10. Hutchinson AB, Fergusson D, Graham ID, Laupacis A, Herrin J, Hillyer CD. Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med. 2001; 11(2):79-85.
11. Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol). 11. 1980; 14:35-40.
12. Mannucci PM. Hemostatic drugs. N Engl J Med. 1998; 339(4):245-253.
13. Colomina MJ, Bagó J, Vidal X, Mora L, Pellisé F. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid. Orthopedics. 2009; 32(2):91.
14. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2007; (4):CD001886.
15. Ickx BE, van der Linden PJ, Melot C, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion. 2006; 46(4):595-605.
16. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis (published online ahead of print December 2, 2008). CMAJ. 2009; 180(2):183-193.
17. Dalmau A, Sabaté A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilonaminocaproic acid or placebo in liver transplantation. Anesth Analg. 2000; 91(1):29-34.
18. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials (published online ahead of print November 12, 2008). Thromb Res. 2009; 123(5):687-696.
19. Ekbäck G, Axelsson K, Ryttberg L. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000; 91(5):1124-1130.
20. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand. 2001; 72(5):442-448.
21. Lozano M, Basora M, Peidro L, et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty (published online ahead of print March 18, 2008). Vox Sang. 2008; 95(1):39-44.
22. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009; 91(6):776-783.
23. Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients (published online ahead of print February 17, 2006). Knee. 2006; 13(2):106-110.
24. Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg. 2004; 99(6):1679-1683.
25. Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied (published online ahead of print December 7, 2007). Transfusion. 2008; 48(3):519-525.
26. Camarasa MA, Ollé G, Serra-Prat M, et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial (published online ahead of print March 10, 2006). Br J Anaesth. 2006; 96(5):576-582.
27. Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty. 2004; 19(4):488-492.
28. Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop. 2005; 76(6):829-832.
29. Husted H, Blønd L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand. 2003; 74(6):665-669.
30. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg. 2000; 120(9):518-520.
31. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplastyprospective randomized study in 40 cases (published online ahead of print October 10, 2003). Int Orthop. 2004; 28(2):69-73.
32. Hynes MC, Calder P, Rosenfeld P, Scott G. The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl. 2005; 87(2):99-101.
33. Lemay E, Guay J, Côté C, Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth. 2004; 51(1):31-37.
34. Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005; 76(3):314-319.